Female Sexual Dysfunction
Low-dose vaginal softgel is approved for treating moderate to severe dyspareunia associated with menopause.
Age and previous hormone replacement therapy did not influence prasterone’s efficacy in treating dyspareunia.
Low-dose testosterone treatment may be considered for HSDD in carefully selected menopausal women after standard therapies have been tried but...
Dr. Richard-Davis served as the Scientific Program Chair of the 2018 NAMS Meeting. In this audiocast she highlights several clinical takeaways...
From the Journals
A trial compares TENS plus diazepam with TENS plus placebo in women with vestibulodynia.
Women undergoing a cancer diagnosis and management plan want their physicians to raise the issue of sexual function, says Dr. Lindau. And...
CHICAGO – Use the menstrual cycle as a vital sign.
Energy-based devices are being used to treat vaginal, vulvar, and sexual symptoms, but we need more clinical evidence of efficacy and safety and...
What works best for genitourinary syndrome of menopause: vaginal estrogen, vaginal laser, or combined laser and estrogen therapy?
There are not enough data to recommend laser therapy over the gold standard, transvaginal estrogen, for treating symptoms of the...
Coverage and expert comment on new insights on HT and Alzheimer disease risk, HT route and sexuality outcomes, mortality in WHI participants, and...
What the evidence and the experts say about the various approaches for prolapse repair Effective surgical management of advanced pelvic organ...